Drug class in one race
Complement C1q drugs for Age-Related Macular Degeneration
2 tracked Complement C1q drugs in the Age-Related Macular Degeneration race. The class explanation lives on the Complement C1q page; the full indication pipeline across every mechanism is on the Age-Related Macular Degeneration page.
2 Phase 3
Head-to-head evidence: ANX007 vs Vonaprument